Aptevo Therapeutics Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Aptevo Therapeutics Inc. (APVO) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$2.58 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-13.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-03-13
- Aptevo Therapeutics Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$68.73M.
- Aptevo Therapeutics Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was $53.56M, a 892.24% increase year-over-year.
- Aptevo Therapeutics Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was $8.26M, a 240.69% increase year-over-year.
- Aptevo Therapeutics Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was $4.34M.
- Aptevo Therapeutics Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$2.58M, a 151.22% decline from fiscal 2016.
- Aptevo Therapeutics Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $5.04M, a 382.66% increase from fiscal 2015.
- Aptevo Therapeutics Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $1.04M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$68.73M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | -$15.17M derived: sum of 2 quarters · filed 2018-03-13 | -$6.92M derived: sum of 3 quarters · filed 2018-03-13 | -$2.58M 10-K · filed 2018-03-13 |
| 2017-09-30 | $53.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $61.82M derived: sum of 2 quarters · filed 2017-11-13 | $66.15M 10-Q · filed 2017-11-13 | $64.94M derived: sum of 4 quarters · filed 2018-03-13 |
| 2017-06-30 | $8.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $12.59M 10-Q · filed 2017-08-10 | $11.38M derived: sum of 3 quarters · filed 2018-03-13 | $16.77M derived: sum of 4 quarters · filed 2018-03-13 |
| 2017-03-31 | $4.34M 10-Q · filed 2017-05-12 | $3.12M derived: sum of 2 quarters · filed 2018-03-13 | $8.52M derived: sum of 3 quarters · filed 2018-03-13 | $10.94M derived: sum of 4 quarters · filed 2018-03-13 |
| 2016-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $4.18M derived: sum of 2 quarters · filed 2018-03-13 | $6.60M derived: sum of 3 quarters · filed 2018-03-13 | $5.04M 10-K · filed 2018-03-13 |
| 2016-09-30 | $5.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $7.82M derived: sum of 2 quarters · filed 2017-11-13 | $6.26M 10-Q · filed 2017-11-13 | $7.42M derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | $2.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $859.00K 10-Q · filed 2017-08-10 | $2.02M derived: sum of 3 quarters · filed 2017-08-10 | $1.45M derived: sum of 4 quarters · filed 2017-08-10 |
| 2016-03-31 | -$1.56M 10-Q · filed 2017-05-12 | -$404.00K derived: sum of 2 quarters · filed 2017-05-12 | -$978.00K derived: sum of 3 quarters · filed 2017-05-12 | |
| 2015-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $586.00K derived: sum of 2 quarters · filed 2017-03-31 | $1.04M 10-K · filed 2017-03-31 | |
| 2015-09-30 | -$574.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-11-14 | -$116.00K 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | $458.00K 10-Q/A · filed 2016-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |